Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLPT NASDAQ:COCH NASDAQ:DCTH NASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$13.59+1.6%$11.21$8.27▼$30.10$401.26M1.31640,125 shs338,271 shsCOCHEnvoy Medical$0.62-5.9%$0.68$0.36▼$1.89$50.67M1.9125,196 shs188,579 shsDCTHDelcath Systems$11.69+6.9%$10.68$8.12▼$16.56$377.67M0.54494,874 shs1.04 million shsVANIVivani Medical$1.14-0.9%$1.20$0.92▼$1.92$99.17M2.31192,362 shs145,122 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+3.80%+5.85%+4.37%+18.20%-3.95%COCHEnvoy Medical-0.33%-5.86%+2.09%-5.72%-56.79%DCTHDelcath Systems+2.53%+3.21%-4.70%+16.76%-33.21%VANIVivani Medical-2.54%-10.85%-3.36%-1.71%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$13.59+1.6%$11.21$8.27▼$30.10$401.26M1.31640,125 shs338,271 shsCOCHEnvoy Medical$0.62-5.9%$0.68$0.36▼$1.89$50.67M1.9125,196 shs188,579 shsDCTHDelcath Systems$11.69+6.9%$10.68$8.12▼$16.56$377.67M0.54494,874 shs1.04 million shsVANIVivani Medical$1.14-0.9%$1.20$0.92▼$1.92$99.17M2.31192,362 shs145,122 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+3.80%+5.85%+4.37%+18.20%-3.95%COCHEnvoy Medical-0.33%-5.86%+2.09%-5.72%-56.79%DCTHDelcath Systems+2.53%+3.21%-4.70%+16.76%-33.21%VANIVivani Medical-2.54%-10.85%-3.36%-1.71%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLPTClearPoint Neuro 2.33Hold$18.0032.45% UpsideCOCHEnvoy Medical 2.00Hold$2.50303.23% UpsideDCTHDelcath Systems 2.43Hold$22.5092.47% UpsideVANIVivani Medical 2.00Hold$3.50207.02% UpsideCurrent Analyst Ratings BreakdownLatest VANI, COCH, DCTH, and CLPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2026CLPTClearPoint Neuro Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$16.005/11/2026DCTHDelcath Systems Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D) ➝ Sell (D+)5/11/2026DCTHDelcath Systems Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/8/2026CLPTClearPoint Neuro Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$16.004/24/2026COCHEnvoy Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026CLPTClearPoint Neuro Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/1/2026COCHEnvoy Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold3/31/2026COCHEnvoy Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$2.503/31/2026VANIVivani Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$4.00 ➝ $3.503/18/2026CLPTClearPoint Neuro B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$18.00 ➝ $20.00(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLPTClearPoint Neuro$36.97M11.02N/AN/A$0.99 per share13.73COCHEnvoy Medical$240K198.61N/AN/A($0.42) per share-1.48DCTHDelcath Systems$85.23M4.73$0.06 per share209.28$3.15 per share3.71VANIVivani MedicalN/AN/AN/AN/A$0.20 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLPTClearPoint Neuro-$25.54M-$1.01N/AN/AN/A-71.57%-140.96%-36.98%8/11/2026 (Estimated)COCHEnvoy Medical-$23.76M-$1.01N/AN/AN/A-9,875.64%N/A-177.92%7/30/2026 (Estimated)DCTHDelcath Systems$2.70M$0.011,169.00N/AN/A0.62%0.51%0.46%8/5/2026 (Estimated)VANIVivani Medical-$26.61M-$0.40N/AN/AN/AN/A-264.04%-79.85%8/12/2026 (Estimated)Latest VANI, COCH, DCTH, and CLPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026CLPTClearPoint Neuro-$0.28-$0.32-$0.04-$0.32$11.97 million$12.13 million5/13/2026Q1 2026VANIVivani Medical-$0.08-$0.08N/A-$0.08N/AN/A5/11/2026Q1 2026COCHEnvoy Medical-$0.14-$0.11+$0.03-$0.08$0.10 million$0.04 million5/7/2026Q1 2026DCTHDelcath Systems-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million3/26/2026Q4 2025VANIVivani Medical-$0.10-$0.09+$0.01-$0.09N/AN/A3/23/2026Q4 2025COCHEnvoy Medical-$0.24-$0.26-$0.02-$0.26$0.03 million$0.08 million3/17/2026Q4 2025CLPTClearPoint Neuro-$0.22-$0.27-$0.05-$0.27$10.40 million$10.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCLPTClearPoint NeuroN/AN/AN/AN/AN/ACOCHEnvoy MedicalN/AN/AN/AN/AN/ADCTHDelcath SystemsN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLPTClearPoint Neuro2.635.794.88COCHEnvoy MedicalN/A2.272.14DCTHDelcath SystemsN/A11.2410.33VANIVivani MedicalN/A3.183.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLPTClearPoint Neuro30.08%COCHEnvoy Medical8.59%DCTHDelcath Systems61.12%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipCLPTClearPoint Neuro6.94%COCHEnvoy Medical7.10%DCTHDelcath Systems19.36%VANIVivani Medical53.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLPTClearPoint Neuro11029.99 million27.91 millionOptionableCOCHEnvoy Medical3476.88 million71.42 millionNot OptionableDCTHDelcath Systems6034.52 million27.84 millionOptionableVANIVivani Medical2086.24 million40.27 millionOptionableVANI, COCH, DCTH, and CLPT HeadlinesRecent News About These CompaniesVivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026May 28, 2026 | markets.businessinsider.comVivani Medical (NASDAQ:VANI) Director Buys $1,999,999.26 in StockMay 20, 2026 | insidertrades.comVivani Medical Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 13, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Purchases 1,587,301 SharesApril 17, 2026 | insidertrades.comWilliams Gregg buys Vivani medical (VANI) shares worth $1.99mApril 16, 2026 | investing.comVivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?April 3, 2026 | zacks.comVivani Medical price target lowered to $3.50 from $4 at H.C. WainwrightApril 2, 2026 | finance.yahoo.comVivani Medical (VANI) price target increased by 10.00% to 5.61March 28, 2026 | msn.comVivani completes first-in-human study of GLP-1 implantMarch 27, 2026 | drugdeliverybusiness.comDVivani Medical, Inc. Advances NPM-139 Semaglutide Implant toward Phase 1 Clinical Study Following Successful LIBERATE-1 Trial and Positive Preclinical DataMarch 26, 2026 | quiverquant.comQVivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 26, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Buys $1,685,497.17 in StockMarch 17, 2026 | insidertrades.comVivani medical director Williams buys shares worth $1.68 millionMarch 16, 2026 | investing.comVivani Medical Introduces Long-Acting Implant for GLP-1 MedicationsMarch 3, 2026 | mddionline.comMWilliams Gregg buys Vivani medical (VANI) shares worth $1.98 millionFebruary 17, 2026 | investing.comCortigent reports positive 6-year findings for brain implant for providing artificial visionJanuary 29, 2026 | massdevice.comVivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026January 29, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,351,351 SharesJanuary 29, 2026 | insidertrades.comWilliams Gregg buys Vivani Medical (VANI) shares for $1.99mJanuary 28, 2026 | investing.comVivani Medical, Inc. Closes $4.5 Million Direct Offering and Private Placement to Support Clinical DevelopmentJanuary 27, 2026 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVANI, COCH, DCTH, and CLPT Company DescriptionsClearPoint Neuro NASDAQ:CLPT$13.59 +0.21 (+1.57%) Closing price 04:00 PM EasternExtended Trading$13.62 +0.03 (+0.19%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.Envoy Medical NASDAQ:COCH$0.62 -0.04 (-5.92%) Closing price 04:00 PM EasternExtended Trading$0.68 +0.06 (+8.87%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Delcath Systems NASDAQ:DCTH$11.69 +0.75 (+6.86%) Closing price 04:00 PM EasternExtended Trading$11.69 0.00 (0.00%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.Vivani Medical NASDAQ:VANI$1.14 -0.01 (-0.87%) Closing price 04:00 PM EasternExtended Trading$1.15 +0.01 (+0.79%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Corning Is Paving AI's Future With Glass The J.M. Smucker Company’s Dividend: Too Sweet to Ignore? Why's Amazon Suddenly Lagging the S&P 500, and Is It a Warning? Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking? From Crypto to AI: Insiders Are Trading These 3 Stocks The Case for Intel Over Pure-Play Quantum Firms Has Temu-Owner PDD's Story Changed After Double Miss? Campbell's Soup Stock: Deep Value and a 7% Dividend Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
